AstraZeneca raises guidance on stellar cancer drugs growth AZ reports strong financial results for 2025, and provides a first peek at the data for its oral GLP-1 contender elecoglipron

#AstraZeneca #PascalSoriot #cancertherapies #oncologyproducts #commercialperformance #blockbusterbrands #cancer #weightloss #genetherapies #antiHER2therapy #prostatecancer #breastcancer #asthma #respiratorysyncytialvirus #RSV #RSVprophylactic #lupus #phase2trials #phase3trials
zurl.co/yLEDf

ICIs have revolutionized treatments but can cause significant toxicity and unusual patterns of progression. Delve into the good, the bad, and the ugly of these agents.

👉 buff.ly/CsLGgTB

#ICI #CancerTherapies

Discover the molecular biology of #glioblastoma and the involved signaling pathways and how this info is being used to develop next-gen therapies.

👉 buff.ly/fYlF1wT

#CancerTherapies #BrainTumor

Accelerated cancer drug approvals deliver limited survival gains at high cost – BioNews Central Early access to new cancer drugs through the FDA’s accelerated approval pathway provided mixed patient benefits and cost Medicare billions, with fewer than half of the drugs subsequently shown to extend survival. ...

Early access to new #CancerDrugs through the #FDA ’s accelerated approval pathway provided mixed #PatientBenefits and cost #Medicare billions, with fewer than half of the drugs subsequently shown to extend survival.
#CancerTherapies #DrugCost #HealthcareCosts

Thomas Vogl accepted into EMBO Young Investigator Programme Read more about his research!

👏 Thomas Vogl, Center for #CancerResearch at #MedUniVienna, has been accepted into the Young Investigator Programme by @embo.org​!

He is investigating how the gut microbiome and #immunesystem together influence the success of #cancertherapies. ⬇️

Immune cells turn damage into repair Researchers discovered that immune cells trigger healing processes in the event of damage to the intestine, for example after radiation therapy.

Researchers found that certain #immunecells can trigger healing in the gut after #cancertherapies using #inflammatory signals – a surprising result, since #gutinflammation was long seen as mainly harmful: go.tum.de/772318

📷J.Fischer

Huge congratulations to @pancreaticcanuk.bsky.social for an incredible event fostering real dialogue between lab and clinical researchers. Great panel discussions on the major challenges (bench/ bedside) and how to bridge science and patient diversity for better #PancreaticCancer #CancerTherapies.

📣 ICYMI: #StanDOM's 2025 Annual Report is now live. From new #CancerTherapies to faster #sepsis diagnostics & an innovative transplant program, this year's report highlights inspiring moments that drive our momentum forward. https://stanford.io/4hq25BJ

This review explores the interplay between the #Nervous and #ImmuneSystems in shaping the #TME, showing how neural activity regulates #TumorImmunity & how tumor-driven immune changes impact neural function, providing insights for new #CancerTherapies.

#STTT: doi.org/10.1038/s413...

Application and Progress of Antibody-Drug Conjugates (ADCs) in the Treatment of Metastatic Triple-Negative Breast Cancer Metastatic triple-negative breast cancer is difficult to treat and has a poor prognosis. But antibody–drug conjugates have emerged as a leading therapeutic strategy for these patients.

Metastatic triple-negative #BreastCancer is difficult to treat and has a poor prognosis.

But antibody–drug conjugates have emerged as a leading therapeutic strategy for these patients.

Find out more 👉 buff.ly/Vo8xRfI

#OncSky #CancerTherapies

We are thrilled to announce Prof @elizahawkes.bsky.social Hawkes, the Chief Clinical Research Officer at the Olivia Newton-John Cancer Research Institute and #Lymphoma doc at Austin Health, as a speaker at #NDLR2026. Eliza’s interests are implementing novel #CancerTherapies into #ClinicalTrails.

We are excited to announce #NDLR2026 speaker, clinician-scientist Prof Rishi Kotecha from the Kids Research Institute. His research aims to develop novel #CancerTherapies for #ChildhoodCancer. He is also leading #ClinicalTrails to improve outcomes for children with #Leukemia.

This new review shows that mechanical forces, like fluid shear stress, in the #TumorMicroenvironment shape #Angiogenesis and #vascular behavior, offering novel strategies for normalizing #tumor cells and unique #CancerTherapies. #medsky
#OpenAccess:
www.sciencedirect.com/science/arti...

Public Health Weekly News – July 4th 2025 Public Health Update : Meat, Soda Risks; AI Beats Doctors; Tick-Borne Allergy and More 🔬 From game-changing cancer treatments to […] The post Public Health Weekly News – July 4th 2025 appeared first on LucidQuest Ventures.

FYI: LucidQuest Views >>> Public Health Weekly News – July 4th 2025 #News #cancertherapies #airpollution Comment below!

Researchers from @isbscience.org are using generative AI to unlock new understanding of human immunity. These discoveries could help predict disease severity and improve #CancerTherapies.

🤔 Learn about TARPON, created by Dr. Jim Heath and Daniel Chen: bit.ly/4kjTAb5

Public Health Weekly News – July 4th 2025 Public Health Update : Meat, Soda Risks; AI Beats Doctors; Tick-Borne Allergy and More 🔬 From game-changing cancer treatments to […] The post Public Health Weekly News – July 4th 2025 appeared first on LucidQuest Ventures.

ICYMI: LucidQuest Views >>> Public Health Weekly News – July 4th 2025 #News #cancertherapies #airpollution Comment below!

Public Health Weekly News – July 4th 2025 Public Health Update : Meat, Soda Risks; AI Beats Doctors; Tick-Borne Allergy and More 🔬 From game-changing cancer treatments to […] The post Public Health Weekly News – July 4th 2025 appeared first on LucidQuest Ventures.

LucidQuest Views >>> Public Health Weekly News – July 4th 2025 #News #cancertherapies #airpollution Comment below!

Sex differences in skin-cancer risk are linked to oestrogen levels Premenopausal women are more likely than men to develop certain cancers. Pathways activated by the sex hormone responsible could be targeted in cancer therapies.

#Medsky🧪#Oncosky #publichealth Premenopausal women are more likely than men to develop certain cancers. Pathways activated by the sex hormone responsible could be targeted in #cancertherapies.
@nature.com
www.nature.com/articles/d41...
PDF

www.nature.com/articles/d41...

浩鼎自創ADC平台GlycOBI® 首宗技術合作案🤝
OBI Pharma Enters ADC Collaboration with Tegmine Therapeutics! 🤝 🚀
#OBIPharma #TegMineTherapeutics #ADCCollaboration #GlycOBI #CancerTherapies

🔬 Learn more:
📄 English Press Release: lnkd.in/gprWcZ7D
📄 中文新聞稿: lnkd.in/gqEqredN

A therapeutic virus against cancer Fusix Biotech, a spin-off from the Technical University of Munich (TUM) develops virus-based cancer therapies that mobilize the body’s own immune defenses.

Jennifer Altomonte and her team at Fusix Biotech, a spin-off from our university, are developing virus-based #cancertherapies that mobilize the body’s own #immunedefenses in the fight against the disease: go.tum.de/312166

#ImmunoTherapy

📷J. Eberle

ABK Biomedical is now on BlueSky! Come chat with us and learn more about how EYE90 fits into the treatment of HCC. #interventionaloncology #precisionmedicine #Y90 #cancertherapies www.abkbiomedical.com

AI-based image analysis detects early organ damage Early warning through AI image analysis: Long before kidney damage occurs as a result of some prostate cancer therapies, kidney volume is slightly reduced.

Lisa Steinhelfer and Friederike Jungmann found that certain #cancertherapies can cause early #kidneydamage, detectable via #AI-analyzed #CTscans. This allows timely treatment adjustments: go.tum.de/787388

#cancertreatment #kidneyfunction

📷A.Eckert

Karyopharm Therapeutics Secures New Talent with Inducement Stock Awards Under Nasdaq Rule Karyopharm Therapeutics has issued 1,850 restricted stock units to new employees, enhancing its workforce to further advance cancer therapies. This follows Nasdaq Listing Rule regulations.

Karyopharm Therapeutics Secures New Talent with Inducement Stock Awards Under Nasdaq Rule #United_States #Karyopharm #XPOVIO #Newton #CancerTherapies

Learning and actioning general principles of cancer cell drug sensitivity - Nature Communications Potential anti-tumor therapies remain to be discovered in cancer cell line high-throughput screening datasets. Here, the authors develop a machine learning approach to infer cancer cell drug sensitivi...

Interesting work to which our institute actively contributed
#cancertherapies #bioinformatics

www.nature.com/articles/s41...

Cancer immunology and immunotherapy Virtual Issue | British Society for Immunology

🔬 Discover how #immunology is transforming cancer treatment! Our joint virtual issue on Cancer Immunology & Immunotherapy highlights cutting-edge research shaping the future of #CancerTherapies.

www.immunology.org/publications...

#CancerResearch
#WorldCancerDay

Lipid imbalances hold the key to chronic inflammation in colon cancer Scientists uncover how disrupted lipid metabolism fuels chronic inflammation in colorectal cancer, offering insights into new therapeutic strategies targeting pro-inflammatory and pro-resolving lipid ...

Lipid imbalances hold the key to chronic inflammation in colon cancer 🔬🧬🌿 www.news-medical.net/news/2024121... #LipidMetabolism #ColorectalCancer #ChronicInflammation #Cancer #Tumors #Inflammation #CancerTherapies #PrecisionMedicine #Gut #Health

"The new findings will contribute to ongoing basic studies in polymerases theta and delta, while also aiding new cancer drugs called polymerase theta inhibitors, which are currently in clinical trials."
www.genengnews.com/topics/cance...
#dnarepair #cancertherapies